Adepu S and Ramakrishna S .2021 .Controlled drug delivery systems: Current status and future directions. Molecules, 19 : 5905.
Alsammarraie HJM,Khan NAK,Mahmud R .2021 .Amphiphilic polymer for formulation of ethanol extract of Moringa oleifera leaves as solid dispersion: Formulation, evaluation and stability studies. Int. J. Drug Deliv, 11(3) : 926-936.
.2005 .ASEAN Guideline on stability study of drug product. Paper presented at the Proceedings of the 9th ACCSQ-PPWG Meeting, : 37.
Askarizadeh M,Esfandiari N,Honarvar B,Sajadian SA,Azdarpour A .2023 .Kinetic modeling to explain the release of medicine from drug delivery systems. Chem. Bio. Eng. Rev., 10(6) : 1006-1049.
Bolourchiana N,Mahboobiana MM,Dadashzadeh S MM .2013 .The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J. Pharm. Res., 12 : 11-20.
Cetin M,Atila A,Kadioglu Y .2010 .Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS Pharm Sci Tech., 11 : 3.
Dongyue Y,Jinghan L,Hanxun W,Hao P,Ting L,Tianshi B,Wei Z,Xiangrong Zhang Z .2022 .Role of polymers in the physical and chemical stability of amorphous solid dispersion: A case study of carbamazepine. Europ. J. Pharm. Sci., 169 : 106086.
Gouda R,Baishya H,Qing Z H .2017 .Application of mathematical models in drug release kinetics of Carbidopa and Levodopa ER tablets. J. Develop. Drugs, 6(171) : 2-11.
He M,Zhu L,Yang N,Li H,Yang Q .2021 .Recent advances of oral film as platform for drug delivery. Int. J. Pharm., 604 : 120759.
ICH-Q1A .2005 .Stability testing of new drug substances and products. , : .
Ke J,Chi M,Zhao J,Liu Y,Wang R,Fan K,Zhou Y,Xi Z,Kong X,Li H,Zeng J,Geng Z J .2023 .Dynamically reversible interconversion of molecular catalysts for efficient electro oxidation of propylene into propylene glycol. J. Am. Chem. Soc., 145(16) : 9104-9111.
Kestin J,Sokolov M,Wakeham WA M .1978 .Viscosity of liquid water in the range -8°C to 150°C. J. Phys. Chem. Ref. Data, 7(3) : 941-948.
Kim MH Kim DH,Nguyen DT,Lee HS,Kang NM,Baek MJ,An J,Yoo J,Yong-H W,Kim KT,Cho CW,Lee JY,Kim DD .2020 .Preparation and evaluation of Eudragit l100-peg proliponiosomes for enhanced oral delivery of celecoxib. , 12 : 718.
Maskova E,Naiserova M,Kubova K,Masek J,Pavlokova S,Urbanova M,Brus J,Vysloužil J,Vetchý D J .2019 .Highly soluble drugs directly granulated by water dispersions of insoluble Eudragit® polymers as a part of hypromellose k100m matrix systems. BioMed. Res. Int., : 2-13.
Clinic Mayo .2022 .. Carbamazepine (oral route), : .
Medina JR,Salazar DK,Hurtado MA,Cortes R,Dominguez-Ramirez AM .2014 .Comparative in vitro dissolution study of carbamazepine immediaterelease products using the USP paddles method and the flow-through cell system. Saudi Pharm. J., 22 : 141-147.
Nandy BC,Gupta A .2014 .A brief review on recent advances of extended release technology employed to design the oral dosage forms. Int. J. Med. Biomed. Studies, 1(6) : 12-24.
Paarakh MP,Jose PA,Setty CM,Peter GV CM .2018 .Release kinetics- concepts and applications. Int. J. Pharm. Res. Tech., 10 : .
Patra RK,Acharya AK,Mahapatra AK,Mallick S AK,Int AK,App AK .2023 .Solubility enhancement of rivaroxaban by solid dispersion with polyethylene glycol 4000. , 15(2) : 78-85.
Shamma RN,Aburahma MH,Mahmoud AA .2016 .Enhancement of carbamazepine dissolution by solid dispersion in peg 4000: Study of the mechanisms of drug-polymer interactions. AAPS Pharm Sci Tech., 17 : 187-198.
Tokunaga S,Ono K,Ito S,Sharmin T,Kato T,Irie K,Mishima K,Satho T,Harada T,Aida TM,Mishima K .2021 .Microencapsulation of drug with enteric polymer Eudragit L100 for controlled release using the particles from gas saturated solutions (PGSS) process. J. Supercrit. Fluids, 167 : 105044.
Tolou-Ghamari Z,Zare M,Habibabadi JM,Najaf MR .2013 .A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J. Res. Med. Sci., Supplement, 1 : S81-S85.
State United .2020 .Pharmaceutical stability. United States Pharmacopeial Convention, : .